PACIRA BIOSCIENCES INC (PCRX) Stock Analyst Ratings
NASDAQ:PCRX - Nasdaq - US6951271005 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 74% to PCRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.69. This target is 10.04% above the current price.
PCRX was analyzed by 14 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about PCRX.
In the previous month the buy percentage consensus was at a similar level.
PCRX was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-30 | Truist Securities | Upgrade | Sell -> Hold |
| 2025-01-14 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-01-13 | Needham | Maintains | Buy -> Buy |
| 2024-12-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-08 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-10-04 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-09-24 | Jefferies | Maintains | Buy -> Buy |
| 2024-08-13 | Truist Securities | Downgrade | Buy -> Sell |
| 2024-08-12 | Needham | Maintains | Buy -> Buy |
| 2024-08-12 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-08-12 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-31 | Needham | Reiterate | Buy -> Buy |
| 2024-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-07-31 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-07-25 | Truist Securities | Maintains | Buy -> Buy |
| 2024-07-03 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-07-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-02 | Needham | Reiterate | Buy -> Buy |
| 2024-07-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | Needham | Maintains | Buy -> Buy |
| 2024-05-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | Needham | Reiterate | Buy -> Buy |
| 2024-03-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-08 | Wedbush | Reiterate | Outperform -> Outperform |